Inventor · disambiguated record
Nader Najafian
Also filed as: NAJAFIAN NADER
0 granted patents·7 pending applications·0 citations·filing 2007–2023
Top patents by PatentIndex Score
7 records- 0173US2024301406A1COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)ALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0261US2021171946A1COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)ALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0359US2023348579A1Dosage and administration of anti-c5 antibodies for treating c5-mediated glomerular nephritis (gn), including lupus nephritis (ln) and/or iga nephropathy (igan)ALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 0452US2025090528A1Use of complement factor d inhibitor for treatment of lupus nephritis and immunoglobulin a nephropathyALEXION PHARMA INC·Filed 2022·Application pending·0 cites
- 0551US2010034782A1Methods of Using Anti-Thymocyte Globulin and Related AgentsNAJAFIAN NADER·Filed 2007·Application pending·0 cites
- 0649US2013344092A1Methods of Using Anti-Thymocyte Globulin and Related AgentsBRIGHAM & WOMENS HOSPITAL·Filed 2013·Application pending·0 cites
- 0746US2019256845A1COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)ALNYLAM PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nader Najafian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →